Women with early-stage breast cancer who couldn't enter clinical trials of cryoablation because of "unfavorable" tumor or patient characteristics nevertheless enjoyed a high rate of treatment success ...
GLENDALE, Calif. (KABC) -- Getting rid of cancerous tumors without surgery? You may have heard of doctors using extreme cold to treat cancer. Now, doctors say it can be effective for early stage ...
The FDA granted marketing authorization for the ProSense Cryoablation System for small, early-stage breast cancer in older women not suitable for surgery, maker IceCure announced. A minimally invasive ...
Medical Device Network on MSN
Podcast: The implications of NICE’s formal recommendation for cryoablation’s use in treating kidney tumours
Dr David Breen, consultant abdominal radiologist at University Hospital Southampton, discusses the implications of NICE's ...
8don MSN
FDA approves cryoablation to treat breast cancer in women over 70 with small, low-risk tumors
The FDA has approved cryoablation — a procedure that freezes and kills small breast tumors without surgery — for women over ...
Cryoablation (also called cryosurgery or cryotherapy) uses very low temperatures to freeze abnormal tissue, destroying it during freezing. A medical professional uses a cryoprobe, which is cooled with ...
While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires ...
Five-year recurrence-free rates of 89.4% and 83.9% indicate durable disease control after ProSense cryoablation in localized small renal masses, supporting its role as a surgery-sparing local ...
CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- IceCure Medical Ltd. (ICCM) (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...
IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...
CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted marketing authorization for ProSense®, a minimally invasive cryoablation treatment for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results